Effects of diminished positive mood and depressed mood upon verbal learning and memory among people with multiple sclerosis

Multiple Sclerosis and Depression: Translation and Adaptation of the Spanish Version of the Chicago Multiscale Depression Inventory and the Study of Factors Associated with Depressive Symptoms

OBJECTIVE

Depressive disorder occurs in up to 50% of persons with Multiple Sclerosis (PwMS). Accurate assessment of depression in MS is essential in clinical settings because depressive symptomatology can affect the clinical course of the disease.

METHODS

We translated, adapted, and tested the Spanish version of the Chicago Multiscale Depression Inventory (CMDI), a specific test to assess depression in neurological disorders. We compare our results with those obtained with previous versions of the questionnaire (English and Italian). Finally, we also analyze the relationship between the results obtained on the CMDI and demographic, clinical, and cognitive variables.

RESULTS

The results obtained with the Spanish version of the CMDI were similar to those observed in previous published versions. We also observed higher depression scores in PwMS (especially in progressive forms) compared with healthy controls. Moreover, depression symptomatology was related to higher disability and fatigue and worse cognitive performance in PwMS.

CONCLUSIONS

The results support the validity of the CDMI in the Spanish population, as well as the association between depression and other characteristic symptoms of MS. These findings also emphasize the importance of good assessment and multidisciplinary treatment of depression in PwMS.

Abnormal functional connectivity in resting state contributes to the weaker emotional sensitivity to reward in depression

INTRODUCTION

Depression is one of the most prevalent mental diseases characterized by distortions in the affective sphere. By using resting-state functional magnetic resonance imaging (rs-fMRI) technique, the current study aimed to investigate neural mechanisms associated with emotional sensitivity to reward, which represented the variation of emotional responsiveness as the degree of reward changing in individuals with depressive symptoms.

METHODS

We recruited 28 participants in elevated depressive symptoms (LD) group and 28 demographic-matched participants in low depressive symptoms (ED) group. After the rs-fMRI scan, participants were asked to complete a sequential risk-taking task, in which they might encounter both reward and loss.

RESULTS

The resting-state functional connectivity (rs-FC) between ventral striatum (VS) and inferior frontal gyrus (IFG) was associated with the emotional sensitivity to reward in LD group. Compared with LD group, participants in ED group showed weaker emotional sensitivity to reward and stronger rs-FC between VS and prefrontal regions.

CONCLUSIONS

The current study highlighted that the functional connectivity between VS and IFG in the resting state was related to the emotional sensitivity to reward in individuals with low depressive symptoms. However, individuals with elevated depressive symptoms exhibited altered functional connectivity between VS and IFG in the resting state, which might contribute to their weaker emotional sensitivity to reward.

Considerations regarding noncredible performance in the neuropsychological assessment of patients with multiple sclerosis: A case series

Determining the validity of data during clinical neuropsychological assessment is crucial for proper interpretation, and extensive literature has emphasized myriad methods of doing so in diverse samples. However, little research has considered noncredible presentation in persons with multiple sclerosis (pwMS). PwMS often experience one or more factors known to impact validity of data, including major neurocognitive impairment, psychological distress/psychogenic interference, and secondary gain. This case series aimed to illustrate the potential relationships between these factors and performance validity testing in pwMS. Six cases from an IRB-approved database containing pwMS referred for neuropsychological assessment at a large, academic medical center involving at least one of the above-stated factors were identified. Backgrounds, neuropsychological test data, and clinical considerations for each were reviewed. Interestingly, no pwMS diagnosed with major neurocognitive impairment was found to have noncredible performance, nor was any patient with noncredible performance in the absence of notable psychological distress. Given the variability of noncredible performance and multiplicity of factors affecting performance validity in pwMS, clinicians are strongly encouraged to consider psychometrically appropriate methods for evaluating validity of cognitive data in pwMS. Additional research aiming to elucidate base rates of, mechanisms begetting, and methods for assessing noncredible performance in pwMS is imperative.